SlideShare a Scribd company logo
Ear Carcinoma
Anatomy to Management
By
Dr. Ayush Garg
Learning Objectives for JRs
Anatomy of Ear
Management of disease
Learning Objectives for SRs
Recent advances in treatment
Anatomy
Epidemiology
Clinical presentation
Diagnostic workup
Pathological classification
Prognostic factors
Staging
General management
Radiotherapy techniques
Results and sequelae of treatment
Anatomy
• The external, middle, and inner components of the ear develop from
the three embryonic layers: ectoderm, mesoderm, and endoderm
• The external ear consists of :
auricle or pinna,
external auditory meatus (canal),
tympanic membrane
CN VIII
Vestibular apparatus
Middle ear
cochlea
TMJ
clivus
Mastoid
Air
cells
• Auricle: composed of elastic cartilage covered with skin.
• External auditory meatus :
connects the tympanic membrane to the exterior
2.4 cm long.
outer 1/3rd - cartilaginous, inner 2/3rd is bony and slightly narrower.
related anteriorly to parotid gland at the TM joint; Inferiorly, jugular bulb
and facial nerve.
 Skin lining is continuous with auricle, outer 1/3rd contains hair follicles,
sebaceous and ceruminous glands.
• Tympanic membrane: made of multiple layers of squamous epithelium;
separates auditory canal from middle ear.
Middle Ear
• Middle ear contains:
auditory ossicles,
tympanic cavity
• Opens into the eustachian tube to communicate with the pharynx.
• Cavity is lined with mucoperiosteal membrane and eustachian tube is lined
with stratified columnar epithelium, has mucous glands in 2/3 rd of the
tube closer to the pharynx.
• Overall length of eustachian tube is 3.5 cm.
Internal Ear
• Lies in petrous portion of temporal bone and consists of :
Bony labyrinth
Membranous labyrinth.
• The membranous labyrinth: holds the organ of hearing, is housed
within the bony labyrinth.
• Cochlea: responsible for hearing
• Vestiblule: responsible for balance
Parts of inner ear
Lateral semicircular canal
Internal auditory canal
Carotid canal
Cochlea
Facial Canal
Sphenoid Sinus
Vestibule
Mastoid air cells
Temporal Lobe (Anterior)
Ossicles
Blood Supply
• Auricle & external auditory canal:
branches of the posterior auricular artery
superficial temporal artery, which arise from the external carotid artery.
• Middle ear:
branches of ascending pharyngeal Artery
middle meningeal arteries
artery of the pterygoid canal.
• Inner ear :
internal auditory artery - branch of the basilar artery
anterior inferior cerebellar artery.
Nerve supply
• The nerves innervating the ear:
cranial nerves V, VIII, IX, and X.
The VIII or vestibulocochlear nerve:
arises at the lateral termination of the internal acoustic meatus and
ends in the brainstem between pons and medulla.
 responsible for auditory and vestibular function.
Lymphatic drainage
• External ear:
Lymphatic vessels of the tragus and anterior external portion of the
auricle: superficial parotid lymph nodes.
posterior and superior aspects of auricle: retroauricular lymph nodes
Lobule: superficial cervical group of lymph nodes.
• Middle ear and mastoid antrum:
sparse lymphatic drainage
parotid nodes and upper deep cervical lymph nodes.
• Inner ear: no lymphatics.
anteriorly
through the
cartilaginous
canal into
the parotid
gland
1
through the concha into the postauricular sulcus
2
posteriorly into the mastoid
4 through the tympanic membrane into the middle ear
3
Into the inner ear through
the round window or otic
capsule
6
Into the anterior
mesotympanum to the
carotid artery and
eustachian tube,
5
Inferomedially into the jugular fossa,
carotid artery, and lower cranial
nerves
8
Along the extratemporal facial nerve into the infratemporal fossa7
Epidemiology
• Malignant disease of the auricle is common but cancers of middle ear and
external auditory canal are rare.
• Incidence: 1 per million.
• External ear:
most common are cutaneous malignancies, related to sun exposure.
Other predisposing factors: otorrhea, chronic eczema, chronic dermatologic
conditions, and chronic ulcerations from trauma.
most common in 60 to 70 years of age.
More common in males.
• Middle ear and the mastoid:
more common in 40 to 60 years of age.
More common in females.
Clinical presentation
• External Ear:
• Basal cell carcinomas are more common than squamous cell
carcinomas (1.3 :1)
• Present as small ulcerations, mostly on helix.
• SCC: lymph nodes metastasis in 10-15%.
• Common LN metastasis sites: parotid glands, upper deep cervical
nodes and postauricular nodes.
• Regional metastasis is higher in advanced disease and may involve
level V LNs.
External Auditory Canal
• Mostly symptomatic
• Pruritus and pain – common
• Advanced cases : Swelling behind the ear, decreased hearing and
facial paralysis
• Spread of the tumor into lymphatic areas: common
• Distant metastases rare
Tumors in cartilaginous portion of canal:
 invade cartilaginous walls and spread to bony canal.
Tumors in bony canal :
more effective barrier preventing spread;
Progress along main axis of canal, eventually invading middle ear or
cartilaginous canal.
Diagnostic Work-Up
• A baseline audiology testing should be performed before any
treatment.
• Both CT and MRI play an important role in vizualizing tumors of ear.
• CT scan:
• CT can show abnormal soft tissue, soft tissue enhancement, and
distortion of the normal tissue planes.
• Most importantly, when evaluating EAC tumor, CT can provide
accurate prediction of bone erosion, such as wall of the EAC, middle
ear, TMJ, carotid artery canal, and jugular fossa and thus can help to
determine the extension and the operability of tumors
• MRI:
• MRI can differentiate the tumor from mastoiditis and cholesteatomas
and provide excellent delineation of soft tissue tumor margins,
muscle infiltration, intracranial extension, dural or cerebral
involvement, and vessel encasement.
• Note:
• Diagnosis is always established by biopsy and occasionally by
aspiration of the exudative material or by surgical exploration.
• A bone scan may be done to determine the changes in temporal bone
around the tumor, but it provides very nonspecific information and is
not a recommended method of evaluation.
Pathologic Classification
• Approx. 85% of the tumors involving auditory canal, middle ear, and mastoid
area are squamous cell carcinomas.
• Others:
Basal cell carcinomas,
Adenocarcinomas,
Adenoid cystic carcinomas,
Melanomas,
Sarcomas, specifically embryonic rhabdomyosarcomas.
Ceruminous gland tumors and papillomas (rarely arise in the auditory canal)
Carcinoid tumor of the middle ear (50 case reports)
Endolymphatic sac tumor or aggressive papillary middle ear tumors:
(characterized by slow growth but extensive local invasion and bone destruction)
• Lesions of the external ear are more easily controlled than middle ear
or mastoid.
• Presence of large lesions involving the middle ear and those with
extension into the temporal bone or soft tissue is a poor prognostic
sign and more difficult to treat.
• No correlation between tumor differentiation, positive margins, or
perineural disease and survival, they are predictor for local control in
tumors involving the temporal bone.
• Seventh cranial nerve palsy associated with middle ear tumors
indicates poor survival
• Spread of tumors to the lymph nodes usually indicates a poor
prognosis
Prognostic Factors
STAGING
• The seventh edition of the American Joint Committee on Cancer
(AJCC) staging manual includes the external ear in its staging system
under Cutaneous Squamous Cell Carcinoma and Other Cutaneous
Carcinomas.
• A group from the University of Pittsburgh proposed a staging system
for squamous cell carcinoma of the external auditory canal and
temporal bone, which was updated in 2002.
• The primary tumor stage is determined by the level of bony erosion,
size, and involvement of the middle ear.
• Lymph node disease is considered advanced stage with poor
prognosis. This staging system has often been cited in the literature
General Management
External Ear
• Most often treated with limited surgery or external radiation therapy.
• Treatment in early stages: irradiation in form of megavolatage
electron beam therapy.
• Dose: 66 – 70 Gy in 1.8 to 2 Gy per fraction for 6.5 – 7 weeks
• Local control rates: 80 -97%
• Surgery : beneficial if lesion has invaded cartilage of ear or extends
medially into auditory canal.
• If squamous cell carcinoma of external ear is treated with surgery
alone: recurrence rate 14- 19%
• Advanced lesions involving ear canal- managed with combination of
irradiation and surgery.
• Treatment of draining lymphatics : not required for early stages of
external ear tumors.
• Prophylactic neck dissection indicated in :
lesions over 4 cm
Lesions with cartilage invasion due to increased risk of nodal spread.
Overall chance of lymph node involvement in tumors of external ear:
16%.
• Interstitial irradiation using afterloading 192Ir, particularly for tumors
<4 cm: effective method of treatment, affording excellent local
control with good cosmesis.
• Radical surgery and postoperative radiation therapy are the accepted
methods of treatment for more advanced lesions of external
auditory canal, middle ear and mastoid.
• Post op radiotherapy dose:
For negative margins: 54 -60 Gy.
For positive margins: upto 66 Gy.
Surgery
• Lesions of the outer part of the auditory canal require local excision with at
least a 1-cm margin between the lesion and the tympanic membrane
• Surgery for tumors of the auditory canal is performed through a U-shaped
incision with elevation of the flap from below.
• A split-thickness skin graft is usually required to cover the deficit along the
auditory canal
• When the tumor involves the bony auditory canal and impinges on the
tympanic membrane but does not involve the middle ear or the mastoid, a
partial temporal bone resection may be necessary; in this procedure, the
auditory canal, tympanic membrane, malleus, and incus are removed along
with the TMJ, and the defect is grafted with a split-thickness skin graft
Middle Ear and Temporal Bone
• In management of temporal bone tumors originating from middle ear and
mastoid area, the surgical options are :
mastoidectomy,
lateral temporal bone resection,
subtotal temporal bone resection,
total temporal bone resection.
• Postoperative radiation therapy is essential to increase chance of local
tumor control as complete resections with clear margins is difficult to
achieve.
• Chemotherapy has not been beneficial in tumors of ear.
New RT Technique
• Stereotactic ablative radiotherapy (SABR) may represent a new
treatment option for organ preservation.
• A study used 37.5 Gy/3 fractions or 40 Gy/5 fractions radiotherapy as
a first-line treatment, resulting in 3-year OS rates: 69% for T1/2, 79%
for T3 (95% CI, 47–93), and 0% for T4 disease with limited toxicities.
Chemotherapy
• Chemotherapy has been used in tumors of the ear.
• The common regimen includes cisplatin, docetaxel, and mitomycin via
intravenous or intra-arterial.
• A meta-analysis suggested that preoperative CRT followed by surgery
may improve the survival of patients with external auditory canal SCC
and that definitive CRT may be equivalent to surgical resection.
• However, additional trials are necessary to determine efficacy
because there was no control trial in this meta-analysis.
Radiation Therapy Techniques
• Tumors involving the pinna can be treated with electron or
megavoltage irradiation.
• Fields : round or polygonal, drawn around the tumor to spare
surrounding normal tissues.
• For small superficial tumors: margins of 1 cm are adequate.
• For extensive lesions: large portal including entire pinna or external
canal with 2- to 3-cm margins around clinically apparent tumor.
• Lesions involving pinna: treated with low dose per fraction(1.8 to 2
Gy daily) to prevent cartilage necrosis.
• Doses of 65 Gy over a period of 6.5 weeks are required to achieve
adequate tumor control.
Lesions of external auditory canal:
treated with irradiation alone or combined with surgery.
Portals: include entire ear and temporal bone with adequate margin
(3 cm).
Volume treated:
includes ipsilateral preauricular, postauricular, and subdigastric
lymph nodes.
Treating lymphatics beyond jugulodigastric area is usually not
necessary.
IMRT:
 Improves target coverage and spares normal critical structures.
advanced external auditory canal and middle ear tumors:
GTV: clinical and radiographic gross disease.
CTV1: GTV with 0.3 -0.5 cms margin to a dose of 66-70 Gy at 2 Gy
per fraction.
CTV2: CTV1 with 0.5 -0.7 cms margin + preauricular and post
auricular LNs with ipsilateral level II LN and parotid gland to a dose
of 63 Gy at 1.8 Gy per fraction.
CTV3: for ipsilateral level III and IV LNs and contralateral level II to a
dose of 56 Gy at 1.6 Gy per fraction.
PTV: 3-5 mm margin around CTVs.
Unresectable Tumors:
• Treated with:
 High-energy ipsilateral electron beam therapy (16 to 20 Mev) alone
or
 Mixed with photons (4 to 6 MV) or
 With wedge pair (superior inferiorly angled beams) techniques using
low-energy photons or
 IMRT.
• Dose: 60 to 70 Gy over 6 to 7 weeks.
• Doses higher than this produces osteoradionecrosis of temporal
bone.
• When electron beam radiation therapy is used, use of water bolus in
external auditory canal and concha reduce auricular complications.
Palliative Radiation Therapy
 In recurrent or advanced disease.
 Pain relief is reported in 61% patients with tumors of auditory canal
and middle ear.
 Recurrences developing after previous irradiation may be retreated
with low-dose radiation therapy: tumor control in 20% patients.
 When small-volume local recurrence occurs after previous radiation
therapy, fractionated high-dose-rate treatment may be considered.
Normal Tissue Dose Constraints
Results of Therapy
Overall 5-year survival rates with combination therapy for :
 Patients with earlier-stage tumors achieve 70% survival rate at 5
years with no evidence of disease
 Tumors involving the middle ear and external auditory canal -40% to
60%
 Negative effect of extent of disease on survival without evidence of
tumor
Sequelae of Treatment
• Possible sequelae with surgery:
Hemorrhage,
Infection,
Loss of facial nerve function,
Rarely, Carotid artery thrombosis.
Occasionally, vertigo is reported after temporal bone resection.
Permanent deafness on operated side.
Radiation therapy sequelae:
 Xerostomia (30% incidence)
 Osteoradionecrosis of temporal bone. (10% incidence after 60 to 65
Gy)
 Cutaneous and Cartilage necrosis of external auditory canal. ( 4%
incidence)
 Rarely, secondary infection and meningitis.
THANK YOU

More Related Content

What's hot

Tumours of external and middle ear
Tumours of external and middle earTumours of external and middle ear
Tumours of external and middle ear
Ramesh Parajuli
 
Management of ca larynx and hypopharynx
Management of ca larynx and hypopharynxManagement of ca larynx and hypopharynx
Management of ca larynx and hypopharynx
Varshu Goel
 
Tumors of nose and paranasal sinus dr.sithanandhakumar -13.06.16
Tumors of nose and paranasal sinus  dr.sithanandhakumar -13.06.16Tumors of nose and paranasal sinus  dr.sithanandhakumar -13.06.16
Tumors of nose and paranasal sinus dr.sithanandhakumar -13.06.16
ophthalmgmcri
 
Tumours of External Auditory Canal and Middle Ear
Tumours of External Auditory Canal and Middle EarTumours of External Auditory Canal and Middle Ear
Tumours of External Auditory Canal and Middle Ear
Dr Harjitpal Singh
 
Nasopharyngeal cancer
Nasopharyngeal cancerNasopharyngeal cancer
Nasopharyngeal cancer
Deepika Malik
 
Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)
Dr. Prashant Surkar
 
CA larynx Presentation - diag. & treatment
CA larynx Presentation - diag. & treatmentCA larynx Presentation - diag. & treatment
CA larynx Presentation - diag. & treatment
Shubham Yadav
 
Total laryngectomy
Total laryngectomyTotal laryngectomy
Total laryngectomy
Balasubramanian Thiagarajan
 
Ca larynx
Ca larynxCa larynx
Ca larynx
Liju Rajan
 
Mastoidectomy
MastoidectomyMastoidectomy
Mastoidectomy
Daria Otgonbayar
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
DrAyush Garg
 
Management of nasopharyngeal cancer
Management of nasopharyngeal cancerManagement of nasopharyngeal cancer
Management of nasopharyngeal cancer
Sailendra Parida
 
Laryngeal surgeries
Laryngeal surgeriesLaryngeal surgeries
Laryngeal surgeries
Deepika Malik
 
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGYCARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
Paul George
 
Surgical management of early laryngeal cancer dr.bhavin
Surgical management of early laryngeal cancer  dr.bhavinSurgical management of early laryngeal cancer  dr.bhavin
Surgical management of early laryngeal cancer dr.bhavin
Dr.Bhavin Vadodariya
 
Management of carcinoma hypopharynx
 Management  of carcinoma hypopharynx  Management  of carcinoma hypopharynx
Management of carcinoma hypopharynx
Isha Jaiswal
 
Ca maxilla
Ca maxillaCa maxilla
Ca maxilla
Vivekanand A
 
Glomus tumors
Glomus tumorsGlomus tumors
Glomus tumors
Ajay Manickam
 
Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary
Himanshu Soni
 
Laryngeal cancer
Laryngeal cancerLaryngeal cancer
Laryngeal cancer
DuongMy6
 

What's hot (20)

Tumours of external and middle ear
Tumours of external and middle earTumours of external and middle ear
Tumours of external and middle ear
 
Management of ca larynx and hypopharynx
Management of ca larynx and hypopharynxManagement of ca larynx and hypopharynx
Management of ca larynx and hypopharynx
 
Tumors of nose and paranasal sinus dr.sithanandhakumar -13.06.16
Tumors of nose and paranasal sinus  dr.sithanandhakumar -13.06.16Tumors of nose and paranasal sinus  dr.sithanandhakumar -13.06.16
Tumors of nose and paranasal sinus dr.sithanandhakumar -13.06.16
 
Tumours of External Auditory Canal and Middle Ear
Tumours of External Auditory Canal and Middle EarTumours of External Auditory Canal and Middle Ear
Tumours of External Auditory Canal and Middle Ear
 
Nasopharyngeal cancer
Nasopharyngeal cancerNasopharyngeal cancer
Nasopharyngeal cancer
 
Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)Esthesioneuroblastoma (ENB)
Esthesioneuroblastoma (ENB)
 
CA larynx Presentation - diag. & treatment
CA larynx Presentation - diag. & treatmentCA larynx Presentation - diag. & treatment
CA larynx Presentation - diag. & treatment
 
Total laryngectomy
Total laryngectomyTotal laryngectomy
Total laryngectomy
 
Ca larynx
Ca larynxCa larynx
Ca larynx
 
Mastoidectomy
MastoidectomyMastoidectomy
Mastoidectomy
 
Carcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to managementCarcinoma nasopharynx anatomy to management
Carcinoma nasopharynx anatomy to management
 
Management of nasopharyngeal cancer
Management of nasopharyngeal cancerManagement of nasopharyngeal cancer
Management of nasopharyngeal cancer
 
Laryngeal surgeries
Laryngeal surgeriesLaryngeal surgeries
Laryngeal surgeries
 
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGYCARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
CARCINOMA MAXILLARY SINUS MANAGEMENT RADIATION ONCOLOGY
 
Surgical management of early laryngeal cancer dr.bhavin
Surgical management of early laryngeal cancer  dr.bhavinSurgical management of early laryngeal cancer  dr.bhavin
Surgical management of early laryngeal cancer dr.bhavin
 
Management of carcinoma hypopharynx
 Management  of carcinoma hypopharynx  Management  of carcinoma hypopharynx
Management of carcinoma hypopharynx
 
Ca maxilla
Ca maxillaCa maxilla
Ca maxilla
 
Glomus tumors
Glomus tumorsGlomus tumors
Glomus tumors
 
Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary Metastasis of Neck Node with Unknown Primary
Metastasis of Neck Node with Unknown Primary
 
Laryngeal cancer
Laryngeal cancerLaryngeal cancer
Laryngeal cancer
 

Similar to Ear carcinoma

Management of ca maxillary sinus
Management of ca maxillary sinusManagement of ca maxillary sinus
Management of ca maxillary sinus
DrAyush Garg
 
Management of sinonasal tract tumors 27082018
Management of sinonasal tract tumors 27082018Management of sinonasal tract tumors 27082018
Management of sinonasal tract tumors 27082018
Varshu Goel
 
Head and neck cancer
Head and neck cancerHead and neck cancer
Head and neck cancer
ShrutiRudraksha
 
Parotid Gland ( Case and Basic Anatomy)
Parotid Gland ( Case and Basic Anatomy) Parotid Gland ( Case and Basic Anatomy)
Parotid Gland ( Case and Basic Anatomy)
Musanna Nabi Chowdhury
 
ACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptxACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptx
Chinmaya Sharma
 
ACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptxACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptx
Chinmaya Sharma
 
hypopharyngealcancer2-151012175726-lva1-app6892.pptx
hypopharyngealcancer2-151012175726-lva1-app6892.pptxhypopharyngealcancer2-151012175726-lva1-app6892.pptx
hypopharyngealcancer2-151012175726-lva1-app6892.pptx
egodoc222
 
Vestibular schwannoma and glomus tumors
Vestibular schwannoma  and glomus tumorsVestibular schwannoma  and glomus tumors
Vestibular schwannoma and glomus tumors
krishnakoirala4
 
Vestibular schwannoma and glomus tumors
Vestibular schwannoma and  glomus tumorsVestibular schwannoma and  glomus tumors
Vestibular schwannoma and glomus tumors
krishnakoirala4
 
Sinonasal tumors dr rk
Sinonasal tumors dr rkSinonasal tumors dr rk
Sinonasal tumors dr rk
raju kafle
 
Unusual non epithelial tumors of head and neck
Unusual non epithelial tumors of head and neckUnusual non epithelial tumors of head and neck
Unusual non epithelial tumors of head and neck
DrAyush Garg
 
TUMORS OF EAR
TUMORS OF EARTUMORS OF EAR
TUMORS OF EAR
KaushalSharma124
 
malignant sinonasal tumors+management.pptx
malignant sinonasal tumors+management.pptxmalignant sinonasal tumors+management.pptx
malignant sinonasal tumors+management.pptx
EmanZayed17
 
Carcinoma maxilla.pptx
Carcinoma maxilla.pptxCarcinoma maxilla.pptx
Carcinoma maxilla.pptx
gracydavid1105
 
ORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptxORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptx
MohammedMujtaba38
 
Benign disease of neck
Benign disease of neckBenign disease of neck
Benign disease of neck
raju kafle
 
DISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptxDISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptx
DeepshikhaKar1
 
Ca external and middle ear staging to management1
Ca external and middle ear staging to management1Ca external and middle ear staging to management1
Ca external and middle ear staging to management1
Dr Durgesh Kumar
 
Vestibular Schwannoma
Vestibular SchwannomaVestibular Schwannoma
Vestibular Schwannoma
Oussama Alserwy
 
Parapharyngeal space tumours
Parapharyngeal space tumoursParapharyngeal space tumours
Parapharyngeal space tumours
Dr./ Ihab Samy
 

Similar to Ear carcinoma (20)

Management of ca maxillary sinus
Management of ca maxillary sinusManagement of ca maxillary sinus
Management of ca maxillary sinus
 
Management of sinonasal tract tumors 27082018
Management of sinonasal tract tumors 27082018Management of sinonasal tract tumors 27082018
Management of sinonasal tract tumors 27082018
 
Head and neck cancer
Head and neck cancerHead and neck cancer
Head and neck cancer
 
Parotid Gland ( Case and Basic Anatomy)
Parotid Gland ( Case and Basic Anatomy) Parotid Gland ( Case and Basic Anatomy)
Parotid Gland ( Case and Basic Anatomy)
 
ACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptxACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptx
 
ACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptxACOUSTIC NEUROMA.pptx
ACOUSTIC NEUROMA.pptx
 
hypopharyngealcancer2-151012175726-lva1-app6892.pptx
hypopharyngealcancer2-151012175726-lva1-app6892.pptxhypopharyngealcancer2-151012175726-lva1-app6892.pptx
hypopharyngealcancer2-151012175726-lva1-app6892.pptx
 
Vestibular schwannoma and glomus tumors
Vestibular schwannoma  and glomus tumorsVestibular schwannoma  and glomus tumors
Vestibular schwannoma and glomus tumors
 
Vestibular schwannoma and glomus tumors
Vestibular schwannoma and  glomus tumorsVestibular schwannoma and  glomus tumors
Vestibular schwannoma and glomus tumors
 
Sinonasal tumors dr rk
Sinonasal tumors dr rkSinonasal tumors dr rk
Sinonasal tumors dr rk
 
Unusual non epithelial tumors of head and neck
Unusual non epithelial tumors of head and neckUnusual non epithelial tumors of head and neck
Unusual non epithelial tumors of head and neck
 
TUMORS OF EAR
TUMORS OF EARTUMORS OF EAR
TUMORS OF EAR
 
malignant sinonasal tumors+management.pptx
malignant sinonasal tumors+management.pptxmalignant sinonasal tumors+management.pptx
malignant sinonasal tumors+management.pptx
 
Carcinoma maxilla.pptx
Carcinoma maxilla.pptxCarcinoma maxilla.pptx
Carcinoma maxilla.pptx
 
ORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptxORAL MALIGNANCIES M.pptx
ORAL MALIGNANCIES M.pptx
 
Benign disease of neck
Benign disease of neckBenign disease of neck
Benign disease of neck
 
DISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptxDISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptx
 
Ca external and middle ear staging to management1
Ca external and middle ear staging to management1Ca external and middle ear staging to management1
Ca external and middle ear staging to management1
 
Vestibular Schwannoma
Vestibular SchwannomaVestibular Schwannoma
Vestibular Schwannoma
 
Parapharyngeal space tumours
Parapharyngeal space tumoursParapharyngeal space tumours
Parapharyngeal space tumours
 

More from DrAyush Garg

Overview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and GeneticsOverview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and Genetics
DrAyush Garg
 
OSTEOSARCOMA
OSTEOSARCOMAOSTEOSARCOMA
OSTEOSARCOMA
DrAyush Garg
 
Overview of brain tumors
Overview of brain tumorsOverview of brain tumors
Overview of brain tumors
DrAyush Garg
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
DrAyush Garg
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
DrAyush Garg
 
Medulloblastoma
MedulloblastomaMedulloblastoma
Medulloblastoma
DrAyush Garg
 
Role of palliative care in oncology
Role of palliative care in oncologyRole of palliative care in oncology
Role of palliative care in oncology
DrAyush Garg
 
Breast cancer screening, prevention and genetic counselling
Breast cancer screening, prevention and genetic counsellingBreast cancer screening, prevention and genetic counselling
Breast cancer screening, prevention and genetic counselling
DrAyush Garg
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
 
Role of hpv in head and neck tumors
Role of hpv in head and neck tumorsRole of hpv in head and neck tumors
Role of hpv in head and neck tumors
DrAyush Garg
 
Carcinoma esophagus
Carcinoma esophagusCarcinoma esophagus
Carcinoma esophagus
DrAyush Garg
 
Cancer vaccines final
Cancer vaccines finalCancer vaccines final
Cancer vaccines final
DrAyush Garg
 
EXTRANODAL EXTENSION
EXTRANODAL EXTENSIONEXTRANODAL EXTENSION
EXTRANODAL EXTENSION
DrAyush Garg
 
Management of ca prostate
Management of ca prostateManagement of ca prostate
Management of ca prostate
DrAyush Garg
 
Clinical Trials in Carcinoma Prostate
Clinical Trials in Carcinoma ProstateClinical Trials in Carcinoma Prostate
Clinical Trials in Carcinoma Prostate
DrAyush Garg
 
Prognostic index in brain metastasis
Prognostic index in brain metastasisPrognostic index in brain metastasis
Prognostic index in brain metastasis
DrAyush Garg
 
Supportive care and quality of life
Supportive care and quality of lifeSupportive care and quality of life
Supportive care and quality of life
DrAyush Garg
 
Palliation brain, spinal and bone mets
Palliation brain, spinal and bone metsPalliation brain, spinal and bone mets
Palliation brain, spinal and bone mets
DrAyush Garg
 
Retinoblastoma
RetinoblastomaRetinoblastoma
Retinoblastoma
DrAyush Garg
 
Small cell lung cancer
Small cell lung cancerSmall cell lung cancer
Small cell lung cancer
DrAyush Garg
 

More from DrAyush Garg (20)

Overview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and GeneticsOverview of Carcinoma Prostate and Genetics
Overview of Carcinoma Prostate and Genetics
 
OSTEOSARCOMA
OSTEOSARCOMAOSTEOSARCOMA
OSTEOSARCOMA
 
Overview of brain tumors
Overview of brain tumorsOverview of brain tumors
Overview of brain tumors
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Medulloblastoma
MedulloblastomaMedulloblastoma
Medulloblastoma
 
Role of palliative care in oncology
Role of palliative care in oncologyRole of palliative care in oncology
Role of palliative care in oncology
 
Breast cancer screening, prevention and genetic counselling
Breast cancer screening, prevention and genetic counsellingBreast cancer screening, prevention and genetic counselling
Breast cancer screening, prevention and genetic counselling
 
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
 
Role of hpv in head and neck tumors
Role of hpv in head and neck tumorsRole of hpv in head and neck tumors
Role of hpv in head and neck tumors
 
Carcinoma esophagus
Carcinoma esophagusCarcinoma esophagus
Carcinoma esophagus
 
Cancer vaccines final
Cancer vaccines finalCancer vaccines final
Cancer vaccines final
 
EXTRANODAL EXTENSION
EXTRANODAL EXTENSIONEXTRANODAL EXTENSION
EXTRANODAL EXTENSION
 
Management of ca prostate
Management of ca prostateManagement of ca prostate
Management of ca prostate
 
Clinical Trials in Carcinoma Prostate
Clinical Trials in Carcinoma ProstateClinical Trials in Carcinoma Prostate
Clinical Trials in Carcinoma Prostate
 
Prognostic index in brain metastasis
Prognostic index in brain metastasisPrognostic index in brain metastasis
Prognostic index in brain metastasis
 
Supportive care and quality of life
Supportive care and quality of lifeSupportive care and quality of life
Supportive care and quality of life
 
Palliation brain, spinal and bone mets
Palliation brain, spinal and bone metsPalliation brain, spinal and bone mets
Palliation brain, spinal and bone mets
 
Retinoblastoma
RetinoblastomaRetinoblastoma
Retinoblastoma
 
Small cell lung cancer
Small cell lung cancerSmall cell lung cancer
Small cell lung cancer
 

Recently uploaded

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 

Recently uploaded (20)

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 

Ear carcinoma

  • 1. Ear Carcinoma Anatomy to Management By Dr. Ayush Garg
  • 2. Learning Objectives for JRs Anatomy of Ear Management of disease Learning Objectives for SRs Recent advances in treatment
  • 3. Anatomy Epidemiology Clinical presentation Diagnostic workup Pathological classification Prognostic factors Staging General management Radiotherapy techniques Results and sequelae of treatment
  • 5. • The external, middle, and inner components of the ear develop from the three embryonic layers: ectoderm, mesoderm, and endoderm • The external ear consists of : auricle or pinna, external auditory meatus (canal), tympanic membrane
  • 6.
  • 7. CN VIII Vestibular apparatus Middle ear cochlea TMJ clivus Mastoid Air cells
  • 8. • Auricle: composed of elastic cartilage covered with skin. • External auditory meatus : connects the tympanic membrane to the exterior 2.4 cm long. outer 1/3rd - cartilaginous, inner 2/3rd is bony and slightly narrower. related anteriorly to parotid gland at the TM joint; Inferiorly, jugular bulb and facial nerve.  Skin lining is continuous with auricle, outer 1/3rd contains hair follicles, sebaceous and ceruminous glands. • Tympanic membrane: made of multiple layers of squamous epithelium; separates auditory canal from middle ear.
  • 9. Middle Ear • Middle ear contains: auditory ossicles, tympanic cavity • Opens into the eustachian tube to communicate with the pharynx. • Cavity is lined with mucoperiosteal membrane and eustachian tube is lined with stratified columnar epithelium, has mucous glands in 2/3 rd of the tube closer to the pharynx. • Overall length of eustachian tube is 3.5 cm.
  • 10. Internal Ear • Lies in petrous portion of temporal bone and consists of : Bony labyrinth Membranous labyrinth. • The membranous labyrinth: holds the organ of hearing, is housed within the bony labyrinth. • Cochlea: responsible for hearing • Vestiblule: responsible for balance Parts of inner ear
  • 11. Lateral semicircular canal Internal auditory canal Carotid canal Cochlea Facial Canal Sphenoid Sinus Vestibule Mastoid air cells Temporal Lobe (Anterior) Ossicles
  • 12. Blood Supply • Auricle & external auditory canal: branches of the posterior auricular artery superficial temporal artery, which arise from the external carotid artery. • Middle ear: branches of ascending pharyngeal Artery middle meningeal arteries artery of the pterygoid canal. • Inner ear : internal auditory artery - branch of the basilar artery anterior inferior cerebellar artery.
  • 13. Nerve supply • The nerves innervating the ear: cranial nerves V, VIII, IX, and X. The VIII or vestibulocochlear nerve: arises at the lateral termination of the internal acoustic meatus and ends in the brainstem between pons and medulla.  responsible for auditory and vestibular function.
  • 14. Lymphatic drainage • External ear: Lymphatic vessels of the tragus and anterior external portion of the auricle: superficial parotid lymph nodes. posterior and superior aspects of auricle: retroauricular lymph nodes Lobule: superficial cervical group of lymph nodes. • Middle ear and mastoid antrum: sparse lymphatic drainage parotid nodes and upper deep cervical lymph nodes. • Inner ear: no lymphatics.
  • 15. anteriorly through the cartilaginous canal into the parotid gland 1 through the concha into the postauricular sulcus 2 posteriorly into the mastoid 4 through the tympanic membrane into the middle ear 3 Into the inner ear through the round window or otic capsule 6 Into the anterior mesotympanum to the carotid artery and eustachian tube, 5 Inferomedially into the jugular fossa, carotid artery, and lower cranial nerves 8 Along the extratemporal facial nerve into the infratemporal fossa7
  • 16. Epidemiology • Malignant disease of the auricle is common but cancers of middle ear and external auditory canal are rare. • Incidence: 1 per million. • External ear: most common are cutaneous malignancies, related to sun exposure. Other predisposing factors: otorrhea, chronic eczema, chronic dermatologic conditions, and chronic ulcerations from trauma. most common in 60 to 70 years of age. More common in males. • Middle ear and the mastoid: more common in 40 to 60 years of age. More common in females.
  • 17. Clinical presentation • External Ear: • Basal cell carcinomas are more common than squamous cell carcinomas (1.3 :1) • Present as small ulcerations, mostly on helix. • SCC: lymph nodes metastasis in 10-15%. • Common LN metastasis sites: parotid glands, upper deep cervical nodes and postauricular nodes. • Regional metastasis is higher in advanced disease and may involve level V LNs.
  • 18. External Auditory Canal • Mostly symptomatic • Pruritus and pain – common • Advanced cases : Swelling behind the ear, decreased hearing and facial paralysis • Spread of the tumor into lymphatic areas: common • Distant metastases rare
  • 19. Tumors in cartilaginous portion of canal:  invade cartilaginous walls and spread to bony canal. Tumors in bony canal : more effective barrier preventing spread; Progress along main axis of canal, eventually invading middle ear or cartilaginous canal.
  • 20.
  • 21. Diagnostic Work-Up • A baseline audiology testing should be performed before any treatment. • Both CT and MRI play an important role in vizualizing tumors of ear. • CT scan: • CT can show abnormal soft tissue, soft tissue enhancement, and distortion of the normal tissue planes. • Most importantly, when evaluating EAC tumor, CT can provide accurate prediction of bone erosion, such as wall of the EAC, middle ear, TMJ, carotid artery canal, and jugular fossa and thus can help to determine the extension and the operability of tumors
  • 22. • MRI: • MRI can differentiate the tumor from mastoiditis and cholesteatomas and provide excellent delineation of soft tissue tumor margins, muscle infiltration, intracranial extension, dural or cerebral involvement, and vessel encasement.
  • 23. • Note: • Diagnosis is always established by biopsy and occasionally by aspiration of the exudative material or by surgical exploration. • A bone scan may be done to determine the changes in temporal bone around the tumor, but it provides very nonspecific information and is not a recommended method of evaluation.
  • 24. Pathologic Classification • Approx. 85% of the tumors involving auditory canal, middle ear, and mastoid area are squamous cell carcinomas. • Others: Basal cell carcinomas, Adenocarcinomas, Adenoid cystic carcinomas, Melanomas, Sarcomas, specifically embryonic rhabdomyosarcomas. Ceruminous gland tumors and papillomas (rarely arise in the auditory canal) Carcinoid tumor of the middle ear (50 case reports) Endolymphatic sac tumor or aggressive papillary middle ear tumors: (characterized by slow growth but extensive local invasion and bone destruction)
  • 25. • Lesions of the external ear are more easily controlled than middle ear or mastoid. • Presence of large lesions involving the middle ear and those with extension into the temporal bone or soft tissue is a poor prognostic sign and more difficult to treat. • No correlation between tumor differentiation, positive margins, or perineural disease and survival, they are predictor for local control in tumors involving the temporal bone. • Seventh cranial nerve palsy associated with middle ear tumors indicates poor survival • Spread of tumors to the lymph nodes usually indicates a poor prognosis Prognostic Factors
  • 27. • The seventh edition of the American Joint Committee on Cancer (AJCC) staging manual includes the external ear in its staging system under Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas. • A group from the University of Pittsburgh proposed a staging system for squamous cell carcinoma of the external auditory canal and temporal bone, which was updated in 2002. • The primary tumor stage is determined by the level of bony erosion, size, and involvement of the middle ear. • Lymph node disease is considered advanced stage with poor prognosis. This staging system has often been cited in the literature
  • 28.
  • 29.
  • 30. General Management External Ear • Most often treated with limited surgery or external radiation therapy. • Treatment in early stages: irradiation in form of megavolatage electron beam therapy. • Dose: 66 – 70 Gy in 1.8 to 2 Gy per fraction for 6.5 – 7 weeks • Local control rates: 80 -97% • Surgery : beneficial if lesion has invaded cartilage of ear or extends medially into auditory canal. • If squamous cell carcinoma of external ear is treated with surgery alone: recurrence rate 14- 19% • Advanced lesions involving ear canal- managed with combination of irradiation and surgery.
  • 31. • Treatment of draining lymphatics : not required for early stages of external ear tumors. • Prophylactic neck dissection indicated in : lesions over 4 cm Lesions with cartilage invasion due to increased risk of nodal spread. Overall chance of lymph node involvement in tumors of external ear: 16%.
  • 32. • Interstitial irradiation using afterloading 192Ir, particularly for tumors <4 cm: effective method of treatment, affording excellent local control with good cosmesis. • Radical surgery and postoperative radiation therapy are the accepted methods of treatment for more advanced lesions of external auditory canal, middle ear and mastoid. • Post op radiotherapy dose: For negative margins: 54 -60 Gy. For positive margins: upto 66 Gy.
  • 33. Surgery • Lesions of the outer part of the auditory canal require local excision with at least a 1-cm margin between the lesion and the tympanic membrane • Surgery for tumors of the auditory canal is performed through a U-shaped incision with elevation of the flap from below. • A split-thickness skin graft is usually required to cover the deficit along the auditory canal • When the tumor involves the bony auditory canal and impinges on the tympanic membrane but does not involve the middle ear or the mastoid, a partial temporal bone resection may be necessary; in this procedure, the auditory canal, tympanic membrane, malleus, and incus are removed along with the TMJ, and the defect is grafted with a split-thickness skin graft
  • 34. Middle Ear and Temporal Bone • In management of temporal bone tumors originating from middle ear and mastoid area, the surgical options are : mastoidectomy, lateral temporal bone resection, subtotal temporal bone resection, total temporal bone resection. • Postoperative radiation therapy is essential to increase chance of local tumor control as complete resections with clear margins is difficult to achieve. • Chemotherapy has not been beneficial in tumors of ear.
  • 35. New RT Technique • Stereotactic ablative radiotherapy (SABR) may represent a new treatment option for organ preservation. • A study used 37.5 Gy/3 fractions or 40 Gy/5 fractions radiotherapy as a first-line treatment, resulting in 3-year OS rates: 69% for T1/2, 79% for T3 (95% CI, 47–93), and 0% for T4 disease with limited toxicities.
  • 36. Chemotherapy • Chemotherapy has been used in tumors of the ear. • The common regimen includes cisplatin, docetaxel, and mitomycin via intravenous or intra-arterial. • A meta-analysis suggested that preoperative CRT followed by surgery may improve the survival of patients with external auditory canal SCC and that definitive CRT may be equivalent to surgical resection. • However, additional trials are necessary to determine efficacy because there was no control trial in this meta-analysis.
  • 37. Radiation Therapy Techniques • Tumors involving the pinna can be treated with electron or megavoltage irradiation. • Fields : round or polygonal, drawn around the tumor to spare surrounding normal tissues. • For small superficial tumors: margins of 1 cm are adequate. • For extensive lesions: large portal including entire pinna or external canal with 2- to 3-cm margins around clinically apparent tumor. • Lesions involving pinna: treated with low dose per fraction(1.8 to 2 Gy daily) to prevent cartilage necrosis. • Doses of 65 Gy over a period of 6.5 weeks are required to achieve adequate tumor control.
  • 38.
  • 39. Lesions of external auditory canal: treated with irradiation alone or combined with surgery. Portals: include entire ear and temporal bone with adequate margin (3 cm). Volume treated: includes ipsilateral preauricular, postauricular, and subdigastric lymph nodes. Treating lymphatics beyond jugulodigastric area is usually not necessary.
  • 40. IMRT:  Improves target coverage and spares normal critical structures. advanced external auditory canal and middle ear tumors: GTV: clinical and radiographic gross disease. CTV1: GTV with 0.3 -0.5 cms margin to a dose of 66-70 Gy at 2 Gy per fraction. CTV2: CTV1 with 0.5 -0.7 cms margin + preauricular and post auricular LNs with ipsilateral level II LN and parotid gland to a dose of 63 Gy at 1.8 Gy per fraction. CTV3: for ipsilateral level III and IV LNs and contralateral level II to a dose of 56 Gy at 1.6 Gy per fraction. PTV: 3-5 mm margin around CTVs.
  • 41.
  • 42. Unresectable Tumors: • Treated with:  High-energy ipsilateral electron beam therapy (16 to 20 Mev) alone or  Mixed with photons (4 to 6 MV) or  With wedge pair (superior inferiorly angled beams) techniques using low-energy photons or  IMRT. • Dose: 60 to 70 Gy over 6 to 7 weeks. • Doses higher than this produces osteoradionecrosis of temporal bone. • When electron beam radiation therapy is used, use of water bolus in external auditory canal and concha reduce auricular complications.
  • 43. Palliative Radiation Therapy  In recurrent or advanced disease.  Pain relief is reported in 61% patients with tumors of auditory canal and middle ear.  Recurrences developing after previous irradiation may be retreated with low-dose radiation therapy: tumor control in 20% patients.  When small-volume local recurrence occurs after previous radiation therapy, fractionated high-dose-rate treatment may be considered.
  • 44. Normal Tissue Dose Constraints
  • 45. Results of Therapy Overall 5-year survival rates with combination therapy for :  Patients with earlier-stage tumors achieve 70% survival rate at 5 years with no evidence of disease  Tumors involving the middle ear and external auditory canal -40% to 60%  Negative effect of extent of disease on survival without evidence of tumor
  • 46. Sequelae of Treatment • Possible sequelae with surgery: Hemorrhage, Infection, Loss of facial nerve function, Rarely, Carotid artery thrombosis. Occasionally, vertigo is reported after temporal bone resection. Permanent deafness on operated side.
  • 47. Radiation therapy sequelae:  Xerostomia (30% incidence)  Osteoradionecrosis of temporal bone. (10% incidence after 60 to 65 Gy)  Cutaneous and Cartilage necrosis of external auditory canal. ( 4% incidence)  Rarely, secondary infection and meningitis.